Recent Price Movement and Market Context
The stock recorded an intraday low of Rs.1693.85, down 2.64% on the day, underperforming its sector by 0.4%. This marks a continuation of a six-day losing streak, during which Poly Medicure has declined by 5.88%. The current price is substantially below its 52-week high of Rs.2936.70, reflecting a year-long depreciation of 37.07%. This contrasts sharply with the broader Sensex, which has gained 8.11% over the same period.
Poly Medicure is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum. Meanwhile, the Sensex opened lower by 94.55 points and is currently trading at 84,591.28, down 0.12%, and remains 1.85% shy of its 52-week high of 86,159.02. The Sensex’s 50-day moving average remains above its 200-day average, indicating a generally positive market trend despite the current dip.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Financial Performance and Valuation Metrics
Despite the stock’s downward trajectory, Poly Medicure’s profits have increased by 22.8% over the past year. However, this growth has not translated into positive returns for shareholders, as the stock’s price has declined sharply. The company’s Price to Earnings to Growth (PEG) ratio stands at 2.2, indicating that the stock is valued expensively relative to its earnings growth.
The Return on Equity (ROE) is recorded at 12.4%, which, while respectable, is accompanied by a high Price to Book Value ratio of 6. This suggests that the stock is trading at a premium compared to its book value, which may be a factor in its current valuation pressures.
Dividend Payout Ratio (DPR) is notably low at 10.70%, reflecting a conservative dividend policy. Additionally, the Debtors Turnover Ratio for the half-year is at 4.02 times, which is among the lowest in its peer group, potentially indicating slower collection cycles.
Sector Position and Market Capitalisation
Poly Medicure holds a significant position within the Healthcare Services sector, with a market capitalisation of Rs.17,638 crores, making it the second largest company in the sector after Lenskart Solutions. The company accounts for 15.60% of the sector’s total market cap and contributes 15.86% to the industry’s annual sales, which stand at Rs.1,712.13 crores.
Institutional investors hold a substantial 23.31% stake in the company, reflecting confidence from entities with extensive analytical resources. The company maintains a low average Debt to Equity ratio of zero, indicating a debt-free balance sheet which is a positive financial attribute.
Poly Medicure Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Mojo Score and Analyst Ratings
Poly Medicure’s current Mojo Score is 37.0, categorised as a Sell rating, a downgrade from its previous Hold status as of 28 May 2025. The Market Cap Grade is 3, indicating a mid-tier valuation relative to market capitalisation. This downgrade reflects the stock’s recent price weakness and valuation concerns despite underlying profit growth.
Over the past year, the stock has underperformed not only the Sensex but also the broader BSE500 index, which has delivered a 5.36% return. Poly Medicure’s negative return of 37.07% highlights the divergence between its financial performance and market valuation.
Summary of Key Concerns
The stock’s decline to a 52-week low is influenced by a combination of factors including its expensive valuation metrics, subdued dividend payout, and relatively low debtor turnover ratio. The persistent trading below all major moving averages underscores the prevailing bearish sentiment. While the company’s debt-free status and institutional backing provide some financial stability, these have not been sufficient to support the stock price amid broader market pressures.
Sector peers and the overall market have shown resilience, with the Sensex maintaining a position close to its 52-week high. Poly Medicure’s underperformance relative to these benchmarks emphasises the challenges it faces in regaining investor confidence at current levels.
Conclusion
Poly Medicure Ltd’s fall to Rs.1693.85 marks a significant technical and psychological level for the stock, reflecting a year-long trend of price erosion despite profit growth. The stock’s valuation and financial ratios suggest a cautious stance by the market, with the current price reflecting these concerns. The company remains a major player in the Healthcare Services sector, but its recent performance highlights the complexities of translating operational results into shareholder returns in a competitive market environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today
